Paper29700554
Platelet-rich plasma as an additional therapeutic option for infected wounds with multi-drug resistant bacteria: in vitro antibacterial activity study.
Çetinkaya RA and 8 others. Eur J Trauma Emerg Surg, 2019. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Platelet-rich plasma as an additional therapeutic option for infected wounds with multi-drug resistant bacteria: in vitro antibacterial activity study. Papers, record 29700554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29700554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Platelet-rich plasma as an additional therapeutic option for infected wounds with multi-drug resistant bacteria: in vitro antibacterial activity study.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Resistance, Multiple, Bacterial | Major topic |
| Klebsiella pneumoniae | Major topic |
| Methicillin-Resistant Staphylococcus aureus | Major topic |
| Platelet-Rich Plasma | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Vancomycin-Resistant Enterococci | Major topic |
| Adult | |
| Carbapenems | |
| Female | |
| Healthy Volunteers | |
| Humans | |
| In Vitro Techniques | |
| Male | |
| Microbial Sensitivity Tests | |
| Plasma | |
| Wound Infection | |
| beta-Lactamases |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10564562 | Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. | Wound Repair Regen | 1999 | https://conductscience.org/library/papers/10564562 | PubMed |
| 2 | 13789187 | Cellular source and charcter of a heatstable bactericidal property associated with rabbit and rat platelets. | J Exp Med | 1961 | https://conductscience.org/library/papers/13789187 | PubMed |
| 3 | 15150818 | A report from the international consensus on diagnosing and treating the infected diabetic foot. | Diabetes Metab Res Rev | 2004 | https://conductscience.org/library/papers/15150818 | PubMed |
| 4 | 17356164 | Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study. | J Bone Joint Surg Br | 2007 | https://conductscience.org/library/papers/17356164 | PubMed |
| 5 | 17960651 | Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. | J Orthop Res | 2008 | https://conductscience.org/library/papers/17960651 | PubMed |
| 6 | 19994800 | Diabetes and peripheral vascular disease. | Acta Chir Belg | 2009 | https://conductscience.org/library/papers/19994800 | PubMed |
| 7 | 20013024 | Platelets in defense against bacterial pathogens. | Cell Mol Life Sci | 2010 | https://conductscience.org/library/papers/20013024 | PubMed |
| 8 | 21073293 | Current medical management of diabetic foot infections. | Expert Rev Anti Infect Ther | 2010 | https://conductscience.org/library/papers/21073293 | PubMed |
| 9 | 21847007 | Enhanced skin wound healing by a sustained release of growth factors contained in platelet-rich plasma. | Exp Mol Med | 2011 | https://conductscience.org/library/papers/21847007 | PubMed |
| 10 | 22329713 | Antibacterial effect of plasma rich in growth factors (PRGF®-Endoret®) against Staphylococcus aureus and Staphylococcus epidermidis strains. | Clin Exp Dermatol | 2012 | https://conductscience.org/library/papers/22329713 | PubMed |
| 11 | 23442413 | Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity. | BMC Microbiol | 2013 | https://conductscience.org/library/papers/23442413 | PubMed |
| 12 | 23447088 | Unique antimicrobial effects of platelet-rich plasma and its efficacy as a prophylaxis to prevent implant-associated spinal infection. | Adv Healthc Mater | 2013 | https://conductscience.org/library/papers/23447088 | PubMed |
| 13 | 23609458 | PRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRP. | J Vis Exp | 2013 | https://conductscience.org/library/papers/23609458 | PubMed |
| 14 | 23671863 | Antibacterial effect of autologous platelet-rich gel derived from subjects with diabetic dermal ulcers in vitro. | J Diabetes Res | 2013 | https://conductscience.org/library/papers/23671863 | PubMed |
| 15 | 23759113 | Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. | Stem Cell Res Ther | 2013 | https://conductscience.org/library/papers/23759113 | PubMed |
| 16 | 24830471 | Platelets: at the nexus of antimicrobial defence. | Nat Rev Microbiol | 2014 | https://conductscience.org/library/papers/24830471 | PubMed |
| 17 | 25108654 | Platelet-rich plasma affects bacterial growth in vitro. | Cytotherapy | 2014 | https://conductscience.org/library/papers/25108654 | PubMed |
| 18 | 25345340 | Antimicrobial activity of platelet-rich plasma and other plasma preparations against periodontal pathogens. | J Periodontol | 2015 | https://conductscience.org/library/papers/25345340 | PubMed |
| 19 | 25722595 | Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective. | J Cutan Aesthet Surg | 2014 | https://conductscience.org/library/papers/25722595 | PubMed |
| 20 | 26238676 | Combating Superbug Without Antibiotic on a Postamputation Wound in a Patient with Diabetic Foot. | Int J Low Extrem Wounds | 2016 | https://conductscience.org/library/papers/26238676 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42827678 | Platelet-rich therapies in cutaneous and mucocutaneous disorders characterized by inflammatory tissue responses: mechanistic insights and clinical evidence. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42827678 | PubMed |
| 41704954 | In vitro antibacterial activity of platelet-rich plasma against Gram-positive and Gram-negative pathogens. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/41704954 | PubMed |
| 41507966 | Risk prediction of encephalitis in hand, foot and mouth disease: a nomogram model based on platelet indices for resource-limited settings. | Ital J Pediatr | 2026 | https://conductscience.org/library/papers/41507966 | PubMed |
| 41361815 | Antibacterial and antibiofilm activity of platelet-rich plasma under different activation conditions against multidrug-resistant MRSA isolated from human skin abscesses. | BMC Biotechnol | 2025 | https://conductscience.org/library/papers/41361815 | PubMed |
| 41210507 | Progress in the clinical application of allogeneic platelet-rich plasma for diabetic foot treatment. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41210507 | PubMed |
| 40612051 | Consensus on the Diagnosis and Treatment of Adult Necrotizing Fasciitis (2025 Edition). | Burns Trauma | 2025 | https://conductscience.org/library/papers/40612051 | PubMed |
| 40307308 | Platelet-rich plasma as a potential antimicrobial agent against multidrug-resistant bacteria in diabetic foot infections. | Sci Rep | 2025 | https://conductscience.org/library/papers/40307308 | PubMed |
| 40213115 | Comparative analysis of cytokine profiles in canine injectable platelet-rich fibrin and platelet-rich plasma. | Int J Vet Sci Med | 2025 | https://conductscience.org/library/papers/40213115 | PubMed |
| 40166040 | Platelet concentrates in diabetic foot ulcers: A comparative review of PRP, PRF, and CGF with case insights. | Regen Ther | 2025 | https://conductscience.org/library/papers/40166040 | PubMed |
| 39729010 | Antibacterial Effect of Canine Leucocyte Platelet-Rich Plasma (L-PRP) and Canine Platelet-Poor Plasma (PPP) Against Methicillin-Sensitive and Methicillin-Resistant Staphylococcus pseudintermedius. | Vet Sci | 2024 | https://conductscience.org/library/papers/39729010 | PubMed |
| 39448627 | Efficacy and safety of allogeneic platelet-rich plasma in chronic wound treatment: a meta-analysis of randomized controlled trials. | Sci Rep | 2024 | https://conductscience.org/library/papers/39448627 | PubMed |
| 39369241 | Platelet-rich fibrin in the management of oral mucosal lesions: a scoping review. | BMC Oral Health | 2024 | https://conductscience.org/library/papers/39369241 | PubMed |
| 38732057 | An In Vitro Study on the Application of Silver-Doped Platelet-Rich Plasma in the Prevention of Post-Implant-Associated Infections. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38732057 | PubMed |
| 38139380 | The Potential of Sheep or Camel Milk Constituents to Contribute to Novel Dressings for Diabetic Wounds. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38139380 | PubMed |
| 38033816 | A review of platelet-rich plasma for enteric fistula management. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/38033816 | PubMed |
| 37570265 | Platelet- Rich Plasma Treatment Supported by Ultrasound Detection of Septa in Recurrent Canine Aural Hematoma: A Case Series. | Animals (Basel) | 2023 | https://conductscience.org/library/papers/37570265 | PubMed |
| 36143034 | Effect of Platelet-Rich Plasma Augmentation on Endoscopy-Assisted Percutaneous Achilles Tendon Repair. | J Clin Med | 2022 | https://conductscience.org/library/papers/36143034 | PubMed |
| 34680774 | Use of Intravesical Injections of Platelet-Rich Plasma for the Treatment of Bladder Pain Syndrome: A Comprehensive Literature Review. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34680774 | PubMed |
| 34671662 | Antibacterial Properties of Canine Platelet-Rich Plasma and Other Non-Transfusional Hemo-Components: An in vitro Study. | Front Vet Sci | 2021 | https://conductscience.org/library/papers/34671662 | PubMed |
| 34583720 | Systematic literature review evaluating evidence and mechanisms of action for platelet-rich plasma as an antibacterial agent. | J Cardiothorac Surg | 2021 | https://conductscience.org/library/papers/34583720 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29700554
GET https://conductscience.org/api/papers/v1/29700554/references?page=2